Biology
You Can’t Unburn the Toast
A lab just reversed a hallmark of aging in donated human skin. You cannot buy it. Here is what the research actually showed, why the sugar story is incomplete, and what a skincare routine can honestly do instead.
On July 14, 2026, a team from Revel Pharmaceuticals, Calico Life Sciences, and the University of Colorado Anschutz Medical Campus published a paper in Nature Communications. They engineered an enzyme that removes a specific form of age-related chemical damage from proteins... damage that had long been treated as effectively irreversible.
It worked. In donated skin from older adults, the enzyme reduced staining for that damage by more than half, bringing it below the level measured in 31-year-old skin. In elderly arterial tissue, the reduction exceeded seventy percent.
The internet did what the internet does. Almost immediately, people wanted to know where to buy it.
You cannot. There is no cream. There is no consumer product. There is no shortcut hiding in the abstract.
The experiment was performed on donated tissue and protein samples, including tissue sections exposed directly to the enzyme overnight. No living human was treated. The authors themselves describe delivery, tissue access, immunogenicity, and functional outcomes as work still to be solved.
That does not make the science less important. It makes the real story more interesting... because it forces us to separate molecular repair in a laboratory from what skincare can honestly accomplish on a living face today.
01
What the Lab Actually Did
The target was Nε-carboxymethyl-lysine, usually shortened to CML. CML is a stable advanced glycation and lipoxidation end product that accumulates on long-lived proteins with age. It can alter protein behavior and also interact with RAGE, a receptor involved in inflammatory and oxidative signaling.
The researchers evolved an enzyme they call CMLase from more than 500 million variants. Its job is unusually specific: oxidize the CML modification and restore the underlying lysine residue.
Reduction in elderly skin
CML staining fell by more than half across epidermal and dermal layers in treated tissue sections.
Reduction in elderly artery
Treated arterial sections showed a substantial drop in measured CML staining.
Younger reference level
Treated elderly skin fell below the CML staining level observed in skin from a 31-year-old donor.
The breakthrough is not that a cream made old skin young. The breakthrough is that a chemical modification once considered permanent was reversed enzymatically in human tissue samples.
02
Why This Is Further Away Than It Looks
The enzyme works. The harder problem is getting it to the damage inside a living person.
Tissue sections in a laboratory expose their targets directly to the treatment solution. Living skin does the opposite. It is built to keep large foreign molecules out. An engineered enzyme is a protein, vastly larger than the small molecules normally used in topical skincare. It would need to cross the outer barrier, remain functional, travel through dense extracellular matrix, and reach enough target sites to matter.
Delivery
Direct access in a tissue section is not the same as penetration through intact living skin.
Function
Removing CML proves chemical repair. It does not yet prove that treated tissue becomes mechanically or visibly younger.
Immunogenicity
A repeatedly administered engineered bacterial enzyme may provoke an immune response and could require further redesign.
Efficiency
The engineered activity remains slower than highly evolved natural protein-editing enzymes.
There is also a distinction the headline cannot carry. CML is generally classified as a non-crosslinking AGE. Removing it may reduce one important form of chemical damage without undoing other structures that contribute to tissue stiffness, including crosslinks such as glucosepane.
None of this means the approach will fail. It means the honest timeline is longer than the beauty industry’s content cycle.
03
What the Damage Actually Is
Your skin is supported by a mesh of long-lived proteins, including collagen. Think of those fibers as the springs in a mattress.
Over time, reactive carbonyl compounds attach chemical residue to those proteins. The broad family of resulting modifications is called advanced glycation end products, or AGEs. CML is one of the most abundant and widely studied.
CML accumulates because long-lived extracellular proteins turn over slowly and the stable modification is not easily removed by normal repair systems. Oxidative stress and inflammation can further feed the chemistry around its formation and signaling.
This is why a meaningful enzyme-based removal platform would matter. It would not merely slow new damage. It could potentially repair a modification already attached to an old protein.
04
The Part the “Sugar” Story Leaves Out
The skincare category usually reduces glycation to one sentence: sugar attaches to collagen.
That is not false. It is incomplete.
AGEs can arise through several connected routes, including reactions involving sugars, sugar oxidation products, inflammatory chemistry, and reactive carbonyls generated through lipid peroxidation. In other words, oxidative damage to lipids can also create reactive fragments capable of modifying nearby proteins.
The reframe
Barrier integrity is not merely about whether skin feels tight after cleansing.
A stable barrier helps limit unnecessary lipid oxidation and the reactive chemistry that can follow it. Barrier care is upstream environmental control.
This does not mean a moisturizer “reverses glycation.” It means the barrier is one of the few practical variables available today for reducing avoidable oxidative stress at the surface.
We built Alchemy 21/12 barrier-first long before this paper appeared. The paper did not create the philosophy. It made the upstream logic even harder to ignore.
05
What a Routine Can Honestly Do Today
Nobody can erase established dermal glycation with a cosmetic routine. Not us. Not anyone else. Not yet.
But that does not make skincare irrelevant. It means each step needs an honest job description.
SWEEP
Move damaged surface buildup along.
The stratum corneum renews continuously. Controlled exfoliation can help release dull, protein-rich surface buildup so it leaves with cells already moving toward shedding.
Meet ENZYME + PHA RESURFACING POLISH →SHUT
Reduce the conditions that feed new damage.
Gentle cleansing and barrier-replenishing moisture help maintain the lipid environment and reduce unnecessary surface stress. Prevention is not reversal, but it changes the conditions around new damage.
REBUILD
Support the appearance of stronger matrix underneath.
Copper-peptide signaling cannot remove old CML. It can support processes associated with new collagen, matrix remodeling, and a firmer, more resilient-looking skin structure over time.
Meet GHK NIGHT CREAM →Sweep. Shut the factory. Rebuild. Not a miracle product... a sequence in which every step has a different job.
06
What We Cannot Do, Said Plainly
We cannot remove established CML from your dermis.
We cannot break glucosepane crosslinks with a cosmetic cream.
We cannot claim an enzyme experiment on donated tissue as a human treatment result.
We cannot make fifty years of molecular history disappear overnight.
Neither can anyone else selling skincare today.
What we can do is formulate around mechanisms that are available now: controlled surface renewal, barrier preservation, environmental defense, hydration, and signaling support.
That answer is less thrilling than an enzyme that rewinds decades of damage in a laboratory dish. It is also honest, actionable, and available without pretending the future has already arrived.
07
The Takeaway
You cannot unburn the toast.
You can stop toasting. You can sweep away what is ready to leave. You can support the production of newer, better-organized structure underneath.
CMLase may eventually become a treatment platform. But translating that proof into a safe, functional treatment for living humans will require delivery, immunogenicity work, functional testing, dosing, and clinical trials.
We will be here doing the less glamorous version in the meantime... and telling you exactly where the line between evidence and ambition still sits.
Research notes
The paper behind the headline
Trabosh N, Smith J, Hsu MYH, et al. “Reversal of protein chemical aging by enzymatic deglycation.” Nature Communications. 2026;17:5926.
View the open-access paper →The article evaluated engineered CMLase in vitro and in donated human tissue samples. It did not evaluate a topical cosmetic, a living human subject, or the finished Alchemy 21/12 products.